Jan. 31, 2008 — Scientists at Washington University School of Medicine in St. Louis are seeking individuals who have depression and are overweight to volunteer for a study evaluating whether a diabetes drug might help improve mood.

Read More

So much for impartial peer review. Last May, a controversial paper in the New England Journal of Medicine ( NEJM ) reported that a popular diabetes drug—rosiglitazone, sold under the brand name Avandia—substantially hikes a user’s risk of heart attack (SN: 6/23/07, p. 397) . But according to an ongoing investigation by the U.S. Senate Committee on Finance, Avandia’s maker, the Philadelphia-based …

Read More

American Diabetes Association say things are getting worse, not better.

Read More

One way diabetes is bad for your blood vessels is by creating too much competition for an amino acid that helps blood vessels relax, researchers say.

Read More

Most people probably view pigs at best as a source of sustenance or, at worst, as filthy, gluttonous animals. But it seems our porcine pals may also prove invaluable in the fight against type 1 diabetes. Researchers are experimenting with new ways of harvesting insulin-producing islet cells from pigs and transplanting them into diabetes sufferers in the hope of one day reducing the need for …

Read More

An enemy to all forms of good health is contributing to Jefferson County being above the state average for residents with diabetes.

Read More

There are approximately 20,000 people living with diabetes in Jefferson County.

Read More

Jan. 31 (Bloomberg) — Takeda Pharmaceutical Co., Japan’s largest drugmaker, reported a 5.9 percent gain in third-quarter profit, helped by sales of its best-selling Actos diabetes pill.

Read More

Jan. 31 (Bloomberg) — Takeda Pharmaceutical Co., Japan’s largest drugmaker, had a 5.9 percent gain in third-quarter profit, helped by sales of its best-selling Actos diabetes pill.

Read More

A Texas doctor leaked confidential research to the makers of the popular diabetes drug Avandia weeks before a study was published tying the drug to higher heart risks, the scientific journal Nature reported Wednesday.

Read More